We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal

Download Mobile App




Events

31 Jul 2024 - 02 Aug 2024
02 Aug 2024 - 04 Aug 2024
20 Aug 2024 - 22 Aug 2024

Tissue-Integrated Sensitive Glucose Nanosenor to Revolutionize Diabetes Management

By HospiMedica International staff writers
Posted on 03 Jan 2024
Print article
Image: The tissue-integrated sensitive glucose nanosenor uses inactive glucose oxidase enzyme for continuous glucose monitoring (Photo courtesy of 123RF)
Image: The tissue-integrated sensitive glucose nanosenor uses inactive glucose oxidase enzyme for continuous glucose monitoring (Photo courtesy of 123RF)

The key task of monitoring blood glucose levels is typically accomplished through the use of enzyme glucose oxidase (GOx)-based electrochemical sensors. Despite their effectiveness, these sensors produce the toxic byproduct hydrogen peroxide and also require cumbersome electrical components and batteries, complicating the development of continuous, implantable monitoring devices. An alternative approach involves single-wall carbon nanotubes (SWCNTs), which, when excited by light, emit near-infrared fluorescence that penetrates tissue and can be captured by non-invasive bioimaging techniques. However, integrating GOx with SWCNTs to create nanosensors is challenging as the typical method for attaching molecules to SWCNTs, sonication, deactivates the GOx molecules.

To address these challenges, scientists at the University of California, Berkeley (Berkeley, CA, USA) have innovated a battery-free fluorescent nanosensor that combines SWCNTs with an inactive form of GOx. This groundbreaking design allows for the continuous, reversible, and non-invasive bioimaging of glucose levels in body fluids and tissues. This development overturns the prevailing belief that GOx-based sensors require active GOx for effective glucose sensing. Through sonication, the team produced GOx-loaded SWCNT sensors capable of accurately and selectively detecting glucose in various mediums like serum, plasma, and even within mouse brain tissue.

According to the researchers, inactive GOx enzyme can still bind to glucose without converting it, and binding alone proved sufficient to modulate the fluorescence signal. In order to be completely independent of GOx activity, the researchers also created a GOx enzyme that even lacked the reactive group for glucose conversion. The resulting apo-GOx-SWCNT sensor was able to detect glucose in body fluids and mouse brain slices as reliably as the original conjugate of SWCNT and natural GOx. The researchers suggest that the use of inactive GOx molecules offers key advantages. For instance, it is possible to simplify the manufacturing process of the GOx-SWCNT nanosensors by utilizing sonication as an effective preparation step. Additionally, since the analyte is not consumed by the enzyme reaction, there are no toxic byproducts produced, and the measurements are intrinsically reversible, enabling the non-invasive continuous monitoring of glucose in tissue fluids.

Related Links:
University of California, Berkeley

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Multi-Parameter Patient Monitor
TR6628-7

Print article

Channels

Surgical Techniques

view channel
Image: Fixation screws for ligament to bone repair (Photo courtesy of 4D Medicine)

Novel Biomaterial Platform Opens Up New Possibilities for Implants and Devices

Resorbable biomaterials, crucial for implantable medical devices, have seen little innovation over decades. Materials like Polylactic Acid (PLA), Polycaprolactone (PCL), and Poly Lactic-co-Glycolic Acid... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: POCT offers cost-effective, accessible, and immediate diagnostic solutions (Photo courtesy of Flinders University)

POCT for Infectious Diseases Delivers Laboratory Equivalent Pathology Results

On-site pathology tests for infectious diseases in rural and remote locations can achieve the same level of reliability and accuracy as those conducted in hospital laboratories, a recent study suggests.... Read more

Business

view channel
Image: The Innovalve transseptal delivery system is designed to enable safe deployment of the Innovalve implant (Photo courtesy of Innovalve Bio)

Edwards Lifesciences Acquires Sheba Medical’s Innovalve Bio Medical

Edwards Lifesciences (Irvine, CA, USA), a leading company in medical innovations for structural heart disease and critical care, has acquired Innovalve Bio Medical LTD. (Ramat Gan, Israel), an early-stage... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.